- 1401. Floor of Mouth SCC
- (UMLS (NCI) C0280300) =Neoplastic Process
| - 1451. Fludarabine/Melphalan
- (UMLS (NCI) C0796646) =Therapeutic or Preventive Procedure
|
- 1402. Floor Stock
- (UMLS (HL7) C1548558) =Idea or Concept =Dispense Method;
| - 1452. Fludarabine/Thalidomide
- (UMLS (NCI) C0935787) =Therapeutic or Preventive Procedure ;
|
- 1403. Floor stock
- [A supply action to restock a smaller more local dispensary. ( HL7V3.0 )] (UMLS (HL7) C1553494) =Manufactured Object =ActPharmacySupplyType;
| - 1453. Fludarabine/UCN-01
- (UMLS (NCI) C0879274) =Therapeutic or Preventive Procedure
|
- 1404. FLOPPY IRIS SYNDROME
- (UMLS (ICD9CM) C1735601) =Pathologic Function ;
| - 1454. Fludiazepam
- (UMLS (NCI) C0060485) =Organic Chemical; Pharmacologic Substance
|
- 1405. Floppy Mitral Valve
- [Prolapse of the mitral valve, often with regurgitation, associated with myxomatous proliferation of the leaflets of the mitral valve. ( NCI )] (UMLS (NCI) C0026267) =Disease or Syndrome ;
=Heart Valve Prolapse;
| - 1455. Flufenazine Decanoate
- [The decanoate salt form of fluphenazine, a phenothiazine with antipsychotic activity. Fluphenazine decanoate exerts its actions by blocking postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia. This prevents the actions of dopamine, thereby reducing the hallucinations and delusions that are associated with schizophrenia. ( NCI )] (UMLS (NCI) C0060580) =Organic Chemical; Pharmacologic Substance =1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-(9CI);
=FLUPHENAZINE DECANOATE 25 MG/ML;
|
- 1406. Flopropione
- (UMLS (NCI) C0060462) =Organic Chemical; Pharmacologic Substance
| - 1456. Flufylline
- (UMLS (NCI) C0060489) =Organic Chemical ;
|
- 1407. Florafur
- (UMLS (NCI) C0919258) Fluorofur;
=Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 1457. fluid
- [nonsolid state of matter in which the atoms or molecules are free to move past each other, as in a gas or liquid. ( CSP )] (UMLS (CSP) C1704353) =Substance ;
=physical state;
=machining fluid;
|
- 1408. Florid Osseous Dysplasia
- (UMLS (NCI) C0555197) =Neoplastic Process
| - 1458. Fluid
- (UMLS (HL7) C1546638) =Intellectual Product =Specimen Source Codes;
|
- 1409. Florifenine
- (UMLS (NCI) C0299748) =Organic Chemical; Pharmacologic Substance
| - 1459. Fluid and Electrolyte Manifestation
- (UMLS (NCI) C1333624) =Finding
|
- 1410. Flosulide
- (UMLS (NCI) C0117885) =Organic Chemical; Pharmacologic Substance ;
| - 1460. fluid dram
- [1 [foz_us]/8 ( HL7V3.0 )] (UMLS (HL7) C1552936) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 1411. Flow
- [The continuous movement characteristic of a liquid or gas. ( NCI )] (UMLS (NCI) C0806140) =Natural Phenomenon or Process ;
| - 1461. fluid flow
- [translocation of fluids. ( CSP )] (UMLS (CSP) C0596578) =Natural Phenomenon or Process ;
=Physical Phenomenon;
=water flow;
microfluidics;
|
- 1412. flow cytofluorometry
- [technique for sorting, selecting or counting individual cells in a suspension as they pass through a tube, especially techniques involving the detection of a cell bound fluorescent label; other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. ( CSP )] (UMLS (CSP) C0016263) =Laboratory Procedure =cell separation;
Medical Devices;
ObservationMethod;
| - 1462. FLUID OVERLOAD
- [abnormal increase in the volume of circulating fluid (plasma) in the body. ( CSP )] (UMLS (ICD9CM) C0546817) =Disease or Syndrome ;
=ASCVD;
Metabolic Disease |
- 1413. Flowable Composite
- [A tooth restorative material that is formulated to create a loose, free-flowing mix. ( NCI )] (UMLS (NCI) C0673997) =Biomedical or Dental Material ;
| - 1463. Fluid, Abdomen
- (UMLS (HL7) C1546633) =Intellectual Product =Specimen Source Codes;
|
- 1414. flower pollen
- [ ] (UMLS (CSP) C1328880) =Plant ;
| - 1464. Fluid, Acne
- (UMLS (HL7) C1546535) =Intellectual Product =Specimen Source Codes;
|
- 1415. flower pollen allergy
- [ ] (UMLS (CSP) C1328881) =Pathologic Function ;
| - 1465. Fluid, Cyst
- (UMLS (HL7) C1546585) =Intellectual Product =Specimen Source Codes;
|
- 1416. flowmeter
- [Devices used to measure the flow of fluids (see RHEOLOGY) or the AIR to measure RESPIRATION. ( MSH )] (UMLS (CSP) C0016266) =Medical Device; Research Device ;
| - 1466. Fluid, Cystostomy Tube
- (UMLS (HL7) C1546584) =Intellectual Product =Specimen Source Codes;
|
- 1417. Flowrate, increased peak expiratory
- [An increase of the greatest rate of flow that can be achieved during forced expiration beginning with the lungs fully inflated. ( NCI )] (UMLS (NCI) C0520842) =Finding
| - 1467. Fluid, Hydrocele
- (UMLS (HL7) C1546668) =Intellectual Product =Specimen Source Codes;
|
- 1418. Floxacrine
- (UMLS (NCI) C0060471) =Organic Chemical; Pharmacologic Substance
| - 1468. Fluid, IV
- (UMLS (HL7) C1546684) =Intellectual Product =Specimen Source Codes;
|
- 1419. Floxuridine/Interferon Alfa
- (UMLS (NCI) C0338161) =Therapeutic or Preventive Procedure
| - 1469. Fluid, Joint
- (UMLS (HL7) C1546687) =Intellectual Product =Specimen Source Codes;
|
- 1420. Floxuridine/Interferon Alfa/Mitomycin
- (UMLS (NCI) C0338139) =Therapeutic or Preventive Procedure
| - 1470. Fluid, Kidney
- (UMLS (HL7) C1546690) =Intellectual Product =Specimen Source Codes;
|
- 1421. Floxuridine/Irinotecan
- (UMLS (NCI) C1327997) =Therapeutic or Preventive Procedure ;
| - 1471. Fluid, Lumbar Sac
- (UMLS (HL7) C1546704) =Intellectual Product =Specimen Source Codes;
|
- 1422. Floxuridine/Leucovorin Calcium/Oxaliplatin
- (UMLS (NCI) C0879521) =Therapeutic or Preventive Procedure ;
| - 1472. Fluid, Other
- (UMLS (HL7) C1546636) =Intellectual Product =Specimen Source Codes;
|
- 1423. Floxuridine/Mitomycin
- (UMLS (NCI) C0281392) =Therapeutic or Preventive Procedure ;
| - 1473. Fluid, Pericardial
- (UMLS (HL7) C1546730) =Intellectual Product =Specimen Source Codes;
|
- 1424. Floxuridine/Octreotide/Streptozocin
- (UMLS (NCI) C0279129) =Therapeutic or Preventive Procedure
| - 1474. Fluid, Renal Cyst
- (UMLS (HL7) C1546766) =Intellectual Product =Specimen Source Codes;
|
- 1425. Floxuridine/Streptozocin
- (UMLS (NCI) C0279128) =Therapeutic or Preventive Procedure
| - 1475. Fluid, Respiratory
- (UMLS (HL7) C1546640) =Intellectual Product =Specimen Source Codes;
|
- 1426. FLT1
- [Gene product of the FLT1 proto-oncogene. A receptor tyrosine kinase, thought to regulate endothelial cell-cell or cell-matrix interactions during vascular development. ( NCI )] (UMLS (NCI) C0378516) =Amino Acid, Peptide, or Protein; Enzyme
| - 1476. Fluid, Shunt
- (UMLS (HL7) C1546776) =Intellectual Product =Specimen Source Codes;
|
- 1427. FLT1
- [This gene is involved in cellular proliferation, differentiation and tyrosine kinase signal transduction. ( NCI )] (UMLS (NCI) C0812298) FLT1 Gene;
FMS-Related Tyrosine Kinase 1 (Vascular Endothelial Growth Factor/Vascular Permeability Factor Receptor) Gene =Gene or Genome | - 1477. fluidity
- [the physical property of a substance that enables it to flow. ( CSP )] (UMLS (CSP) C0596579) =Quantitative Concept ;
=Physical Phenomenon;
|
- 1428. FLT3
- [Fms-related receptor tyrosine kinase; growth factor receptor for hematopoietic stem and progenitor cells. (LocusLink) ( NCI )] (UMLS (NCI) C0251006) =Amino Acid, Peptide, or Protein; Receptor ;
| - 1478. Fluimucetin
- (UMLS (NCI) C1510761) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
|
- 1429. FLT3
- [This gene plays a role in hematopoiesis and may function as a growth factor receptor. ( NCI )] (UMLS (NCI) C1333568) FLT3 Gene;
FMS-Related Tyrosine Kinase 3 Gene =Gene or Genome | - 1479. Fluimucil
- (UMLS (NCI) C0699251) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 1430. Flt3 Ligand/gp100 Antigen
- (UMLS (NCI) C0677845) =Therapeutic or Preventive Procedure ;
| - 1480. Fluindione
- (UMLS (NCI) C0117899) =Organic Chemical; Pharmacologic Substance ;
|
- 1431. Flt3 Ligand/gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen/Tyrosinase
- (UMLS (NCI) C0796381) Flt3L/gp100/IFA/MART-1/TYR =Therapeutic or Preventive Procedure ;
| - 1481. fluke
- [class of parasitic flukes consisting of three subclasses, Monogenea, Aspidogastrea, and Digenea; the digenetic trematodes are the only ones found in man; organisms are endoparasites and require two hosts to complete their life cycle. ( CSP )] (UMLS (CSP) C0040818) =Invertebrate ;
=flatworm;
=Schistosoma |
- 1432. Flt3 Ligand/gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide
- (UMLS (NCI) C0879327) =Therapeutic or Preventive Procedure
| - 1482. Flumedroxone
- (UMLS (NCI) C0060492) =Steroid; Pharmacologic Substance
|
- 1433. Flt3 Ligand/gp100 Antigen/MART-1 Antigen/Tyrosinase
- (UMLS (NCI) C0796380) Flt3L/gp100/MART-1/TYR =Therapeutic or Preventive Procedure ;
| - 1483. FLUMETHASONE
- [An anti-inflammatory glucocorticoid used in veterinary practice. ( MSH )] (UMLS (NCI) C0016294) =Steroid; Pharmacologic Substance; Hormone
|
- 1434. FLT3LG
- [This gene plays a role in the proliferation of hematopoietic progenitor cells. ( NCI )] (UMLS (NCI) C1333567) FLT3LG Gene;
FMS-Related Tyrosine Kinase 3 Ligand Gene =Gene or Genome | - 1484. Flumethasone Pivalate
- (UMLS (NCI) C0060494) =Steroid; Pharmacologic Substance
|
- 1435. FLT4
- [This gene plays an essential role in the development of embryonic cardiovasculature and lymphatic vessel formation. ( NCI )] (UMLS (NCI) C1333569) FLT4 Gene;
FMS-Related Tyrosine Kinase 4 Gene =Gene or Genome | - 1485. FluMist
- (UMLS (NCI) C1311943) =Organic Chemical; Pharmacologic Substance; Immunologic Factor
|
- 1436. FLT4 Ligand
- [Encoded by human VEGFC Gene (PDGF/VEGF Family), VEGFC is expressed in spleen, lymph node, thymus, appendix, bone marrow, heart, placenta, ovary, skeletal muscle, prostate, testis, colon, and small intestine, as well as fetal liver, lung, and kidney. Active in angiogenesis, endothelial growth, and vascular permeability, VEGFC may maintain adult lymphatic endothelium. A FLT4 ligand, VEGFC is a 419-amino acid 47 kD (precursor) disulfide-linked homodimeric secreted polypeptide with C-terminal cysteine-rich BR3P repeats and similar to VEGF and VEGFB/VRF. VEGFC can also activate endothelial VEGFR2 (KDR/FLK1). VEGFC proteolytic maturation generates isoforms with increased VEGFR3 activity; fully processed VEGFC activates VEGFR2. Mature VEGFC is mostly composed of two VEGF homology domains bound by non-covalent interactions. (OMIM, Swiss-Prot, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C0388911) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 1486. flunarizine
- [Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. ( MSH )] (UMLS (CSP) C0016295) =Organic Chemical; Pharmacologic Substance ;
|
- 1437. FLU D/T AVIAN FLU VIRUS
- [ ] (UMLS (ICD9CM) C1955789) Influenza due to identified avian influenza virus;
=Disease or Syndrome | - 1487. FLUNISOLIDE
- [A synthetic corticosteroid with antiinflammatory and antiallergic properties. Flunisolide is a glucocorticoid receptor agonist that binds to cytoplasmic glucocorticoid receptors and subsequently translocates to the nucleus where it initiates the transcription of glucocorticoid-responsive genes such as lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes, both are potent mediators of inflammation. ( NCI )] (UMLS (NCI) C0060501) =Steroid; Pharmacologic Substance =(6alpha,11beta,16alpha)-6,9-Difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione;
[NT200] ANTI-INFLAMMATORIES, NASAL;
[RE101] ANTI-INFLAMMATORIES, INHALATION;
=flunisolide 0.25 MG/ACTUAT;
flunisolide 0.025 MG/ACTUAT |
- 1438. Flu Matrix
- [A short chain synthetic antigenic peptide derived from the Influenza virus A matrix protein presented by HLA-A2 multi histocompatibility complex (MHC) class I molecules. The Flu-Matrix antigen stimulates the lytic functions of the alphabeta CD8+ cytotoxic T lymphocytes (CTLs) which are part of the acquired immune system capable of eradicating virus-infected or malignant-tumor cells. ( NCI )] (UMLS (NCI) C0796514) Flu Matrix Antigen;
Flu Matrix Peptide;
Flu Matrix Protein;
FLU-MP;
Influenza Matrix Peptide =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 1488. flunitrazepam
- [A benzodiazepine with pharmacologic actions similar to those of DIAZEPAM that can cause ANTEROGRADE AMNESIA. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug. ( MSH )] (UMLS (CSP) C0016296) =Organic Chemical; Pharmacologic Substance ;
|
- 1439. Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3 /MART-1 Antigen/Melan-A/NY-ESO-B/QS21/Tyrosinase Peptide
- (UMLS (NCI) C1327763) Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3 /MART-1 Antigen/NY-ESO-B/QS21/Tyrosinase Peptide;
=Therapeutic or Preventive Procedure; ;
| - 1489. FLUNIXIN
- (UMLS (NCI) C0060502) =Organic Chemical; Pharmacologic Substance
|
- 1440. Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3/MART-1 Antigen/Melan-A/NY-ESO-B/Tyrosinase Peptide
- (UMLS (NCI) C1327764) Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3/MART-1 Antigen/NY-ESO-B/Tyrosinase Peptide;
=Therapeutic or Preventive Procedure; ;
| - 1490. Flunoxaprofen
- (UMLS (NCI) C0060504) =Organic Chemical; Pharmacologic Substance
|
- 1441. Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/Melan-A/NY-ESO-B/QS21/Tyrosinase Peptide
- (UMLS (NCI) C1327766) Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/NY-ESO-B/QS21/Tyrosinase Peptide =Therapeutic or Preventive Procedure; ;
| - 1491. Fluor-Op
- (UMLS (NCI) C0720477) =Steroid; Pharmacologic Substance
|
- 1442. Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/Melan-A/NY-ESO-B/Tyrosinase Peptide
- (UMLS (NCI) C1327765) Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/NY-ESO-B/Tyrosinase Peptide =Therapeutic or Preventive Procedure; ;
| - 1492. fluorene
- [A family of diphenylenemethane derivatives. ( MSH )] (UMLS (CSP) C0016311) =Organic Chemical; Hazardous or Poisonous Substance ;
=PAH;
=hexafluorenium;
|
- 1443. Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/Tyrosinase Peptide
- (UMLS (NCI) C0796515) =Therapeutic or Preventive Procedure
| - 1493. FLUORESCEIN
- [phthalic yellow-green dye used as an indicator and diagnostic aid; used therapeutically as a diagnostic aid in corneal injuries and corneal trauma; also used to label antibodies for fluorescence. ( CSP )] (UMLS (NCI) C0060520) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =benzopyran;
Fluoresceins;
fluorescent dye;
[OP900] OPHTHALMICS, OTHER =Fluorescein Sodium;
|
- 1444. flu vaccine
- [orthomyxovirus vaccine; the composition of the vaccine is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains; the vaccine is usually bivalent or trivalent, containing one or two influenza virus A strains and one influenza virus B strain. ( CSP )] (UMLS (CSP) C0021403) =Organic Chemical; Pharmacologic Substance; Immunologic Factor =viral vaccine;
Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType;
| - 1494. Fluorescein angiography
- [visualization of a vascular system after intravenous injection of a fluorescein solution; images may be photographed or televised; used especially in studying the retinal and uveal vasculature. ( CSP )] (UMLS (HL7) C0016313) =Diagnostic Procedure =Angiogram;
Modality |
- 1445. FLU W MANIFESTATION NEC
- [ ] (UMLS (ICD9CM) C0155871) =Disease or Syndrome
| - 1495. Fluorescein Angioscopy
- (UMLS (HL7) C1548855) =Health Care Activity =Consent Type;
|
- 1446. FLU W RESP MANIFEST NEC
- (UMLS (ICD9CM) C0021414) =Disease or Syndrome
| - 1496. Fluorescein Sodium
- (UMLS (NCI) C0147866) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =FLUORESCEIN;
=FLUORESCEIN SODIUM 0.6 MG;
FLUORESCEIN SODIUM 1 MG;
FLUORESCEIN SODIUM 10 %;
FLUORESCEIN SODIUM 9 MG;
FLUORESCEIN SODIUM 0.25 %;
FLUORESCEIN SODIUM 2 %;
FLUORESCEIN SODIUM 25 % |
- 1447. Fluanisone
- (UMLS (NCI) C0060473) =Organic Chemical; Pharmacologic Substance
| - 1497. fluorescence
- [absorption of a photon of light followed, after a delay, by emission of a photon of longer wavelength. ( CSP )] (UMLS (CSP) C0016315) =Natural Phenomenon or Process =light emission;
|
- 1448. Fluatox
- (UMLS (NCI) C1510760) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 1498. fluorescence anisotropy
- [ ] (UMLS (CSP) C0085813) =Natural Phenomenon or Process ;
|
- 1449. Fluazuron
- (UMLS (NCI) C0536903) =Organic Chemical; Pharmacologic Substance
| - 1499. Fluorescence Light Microscopy
- [microscope that irradiates fluorescent materials or specimens with ultraviolet, violet, and occasionally blue light, causing the materials to fluoresce. ( CSP )] (UMLS (NCI) C0026022) =Laboratory Procedure ;
=microscopy;
|
- 1450. Fluctuations of weight
- (UMLS (NCI) C0241729) =Finding
| - 1500. fluorescence polarization
- [measurement of the polarization of fluorescent light from solutions or microscopic specimens; used to provide information concerning molecular size, shape, and conformation, molecular anisotropy, electronic energy transfer, molecular interaction, including dye and coenzyme binding, and the antigen-antibody reaction. ( CSP )] (UMLS (CSP) C0016316) =Laboratory Procedure =optical polarization;
|
home 
Armenian-English 
top